PCVX FY 2021 Earnings — Vaxcyte, Inc. Revenue & Financial Results | Market Cap Arena

PCVXVaxcyte, Inc.

$9B

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$104M

Net Income

-$100M

EPS (Diluted)

$-1.93

Cash Flow

Operating Cash Flow

-$121M

Free Cash Flow

-$128M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$324M

Total Liabilities

$40M

Stockholders' Equity

$284M

Cash & Equivalents

$69M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	-$1M	+100.0%
Operating Income	-$104M	-$90M	-15.7%
Net Income	-$100M	-$89M	-12.2%